Clinical Trial Update: Five-year Recurrence After LCME

View source ↗

Summary

This clinical trial update reports five-year recurrence data for colon cancer patients treated with LCME. The study includes stages I to III.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Snippet

Sponsor: Gødstrup Hospital | Conditions: Colon Cancer Stage I, Colon Cancer Stage II | Status: COMPLETED